Founded with a mission to innovate medical devices for spinal and orthopedic treatments, MiRus focuses on creating advanced solutions for degenerative and deformative conditions. Leveraging pioneering material science inspired by NASA, MiRus has developed Rhenium-based medical alloys that enhance the safety, durability, and minimally invasive nature of surgical implants. Their integrated platform addresses the entire surgical process, from pre-operative planning to intra-operative execution, aiming to improve patient outcomes in cardiovascular and orthopedic care.

Notable figures affiliated with MiRus include experts in material science and medical technology, contributing to the company's groundbreaking advancements. MiRus has attracted significant investment from venture capital firms specializing in healthcare innovation. Key achievements include the successful development and clinical adoption of their Rhenium-based implants, which have set new standards in the industry. The overall impact of MiRus is marked by its contribution to making surgeries less invasive and improving the longevity and performance of medical implants, thereby enhancing the quality of life for patients worldwide.